Jagsonpal Pharmaceuticals Completes 85% Aequitas Acquisition

Disclosure Information

Event Disclosure

Jagsonpal Pharmaceuticals Limited has completed the acquisition of 85% equity stake in Aequitas Healthcare Private Limited ("Aequitas").

Background and Timeline

This completion follows previous corporate disclosures made to the exchanges:

• Initial intimation dated June 29, 2026 regarding the proposed acquisition
• Further updates provided on July 7, 2026
• Additional updates provided on July 8, 2026

Financial Impact

Financial impact of the acquisition is not quantified in this disclosure.

Corporate Action

The acquisition represents a significant majority stake (85%) in Aequitas Healthcare Private Limited, indicating a controlling interest in the acquired entity.

#Tags: #JagsonpalPharmaceuticals #AequitasHealthcare #Regulation30 #SEBIDisclosure #Acquisition #Neutral